Showing results (361-370 of 601) with videos related to
Sort By:
Pageof 61
Neurology|September 20, 2013
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosisClemens Warnke, Anne K Mausberg, Mark Stettner, et al.Plos One|October 7, 2014
FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathiesGerd Meyer zu Hörste, Steffen Cordes, Anne K Mausberg, et al.Ebiomedicine|March 13, 2021
Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competenceAnastasia Manousi, Peter Göttle, Laura Reiche, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 27, 2015
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS studyJeffrey A Cohen, Bhupendra Khatri, Frederik Barkhof, et al.Neuromuscular Disorders : NMD|September 5, 2002
Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathyJennifer L Dawkins, Sonal Brahmbhatt, Michaela Auer-Grumbach, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 7, 2013
Visual evoked potentials in neuromyelitis optica and its spectrum disordersMarius Ringelstein, Ingo Kleiter, Ilya Ayzenberg, et al.The Lancet. Neurology|March 12, 2014
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trialLudwig Kappos, Hans-Peter Hartung, Mark S Freedman, et al.Annals of Clinical and Translational Neurology|August 8, 2023
SARS-CoV-2 vaccination and infection in ozanimod-treated participants with relapsing multiple sclerosisBruce A C Cree, Rachel Maddux, Amit Bar-Or, et al.Journal of Neuroinflammation|March 9, 2018
Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis modelMichael Dietrich, Niklas Helling, Alexander Hilla, et al.Journal of Neuroimmunology|July 17, 2003
The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosisHeinz Wiendl, Oliver Neuhaus, Matthias Mehling, et al.Pageof 61